Alinity test kits

Active Awarded Last action

Contract number
36C24526N0133
Awardee
Awarding agency
Obligated
$1,134,904

Award facts

Contract value 25% obligated
  • $1,134,903.91 Current, with exercised options
  • $4,536,615.64 Potential, with all options
Completion date 24% complete
  • Current, with exercised options
  • Potential, with all options
NAICS code
334516 Analytical Laboratory Instrument Manufacturing
PSC
6630 Chemical Analysis Instruments
Set-aside
No set-aside
Competition
Full and Open Competition · 3 offers Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Rosemont, IL 60018, USA

Award details come from SAM.gov/FPDS.

About this award

Abbott Molecular Inc., a subsidiary of Abbott Laboratories, was awarded a delivery order valued at $4.54 million for Alinity test kits under the General Services Administration's Critical Analyzers, Laboratory (FSS-66-III) schedule. The contract, awarded on November 1, 2025, is structured as a firm fixed-price delivery order with an ultimate completion date of October 31, 2029, and will be performed in Des Plaines, Illinois. The award supports the Department of Veterans Affairs' Veterans Integrated Service Network 5 and represents no set-aside designation, reflecting Abbott Molecular's status as an established large business in the medical diagnostics sector. This delivery order builds upon Abbott Molecular's extensive portfolio of federal healthcare contracts, particularly its significant blanket purchase agreements with the VA for molecular diagnostic supplies and reagent products.

Abbott Molecular has positioned itself as a critical supplier of in-vitro diagnostic testing capabilities across the federal healthcare system, with particular strength in infectious disease testing, including COVID-19, HIV, HPV, and hepatitis screening applications. The company's Alinity platform represents a core diagnostic solution for federal medical facilities, and this award demonstrates the continued reliance of Veterans Affairs on Abbott's molecular testing infrastructure to support patient care delivery across its integrated service networks. The contract aligns with the company's historical pattern of supplying reagents and test kits to VA facilities through structured GSA Schedule vehicles, ensuring standardized procurement and consistent availability of critical laboratory testing materials.

Quick answers

Who was awarded contract 36C24526N0133?

36C24526N0133 was awarded to Abbott Molecular Inc. by Veterans Integrated Service Network 5 (Veterans Health Administration) on November 1, 2025.

How much is contract 36C24526N0133 worth?

The government has obligated $1,134,904 on 36C24526N0133. Its potential value, with all options, is $4,536,616.

Is contract 36C24526N0133 an order under another contract?

Yes. 36C24526N0133 is a delivery order under V797P7323A, a federal supply schedule, on Critical Analyzers, Laboratory (FSS-66-III).

Was contract 36C24526N0133 competed?

The extent of competition for 36C24526N0133 was full and open competition. The government received 3 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award